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If, as first postulated by Burnet, tolerance to self-antigens is an acquired character- 
istic of the lymphoid system, then clones with anti-self recognition capability should 
arise during lymphopoiesis (1).  In the absence of an efficient mechanism  for inacti- 
vating such clones, autoimmunity would regularly be induced whenever any of these 
clonotypes achieved effector capacity.  Three basic  types of model  for inactivating 
anti-self-reactive clones have been proposed to account for the relative infrequence of 
autoimmune events: clonal abortion, clonal deletion  (2-12), and active suppression 
(13-22). All three models have found experimental support in the literature although 
the  details  of the  intercellular  and  intracellular  mechanisms  by  which  they  are 
presumed to operate still remain largely undefined. 
The  theory of clonal abortion  proposes  that  a  phase  in  lymphocyte maturation 
exists when contact with antigen can only result in immunological paralysis (23). The 
early and continuous presence of self-antigens in appropriate concentrations would 
therefore ensure that clones having anti-self receptors would be permanently inacti- 
vated. Recent studies on the sequential appearance of surface Ig isotypes during B- 
cell ontogeny have  been  interpreted  in  favor of this  viewpoint  (24,  25).  Thus  the 
heightened susceptibility of neonates to tolerance induction has been associated with 
the presence of/~-chain-bearing antigen receptors on some B-cell precursor populations 
before their maturation into #- nd 8-chain-bearing immunocompetent cells.  Another 
interpretation of self-tolerance, viz. clonal deletion, predicts that  the outcome of an 
encounter between an imrnunocompetent cell and antigen depends on the capacity of 
the  cell  to  qualitatively  and  quantitatively  discriminate  between  tolerogenic  and 
immunogenic  signals  (26).  The  observation  that  neonatal  B  cells  are  resistant  to 
tolerance induction  in the presence of specific T-cell help would  favor this type of 
interpretation (12). 
Active  suppression,  which  appears  to  be  particularly  relevant  in  the  general 
regulation of immune responsiveness, has also been proposed to account at least  in 
part for regulation of responsiveness to self (27). Although it is possible to operationally 
reconcile suppressor cells with a clonal deletion mechanism, some proponents of this 
theory favor a type of homeostatic equilibrium between suppressors and a functionally 
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inactivated though undeleted pool of target T  and/or B lymphocytes (19). 
Most  in  vivo  self-tolerance  models  are  based  on  extrapolations  of  data  from 
autoimmune  phenomena  (27)  or  from  experiments  with  adult  immunocompetent 
animals  in which the time of antigen  exposure  is  not considered  a  critical  develop- 
mental feature of the system (18). In view of these considerations, we felt it appropriate 
in the present study to utilize a  model system for tolerance induction which permits 
access of the  extrinsic  test  antigen  to the  fetus well  before  immunocompetent  cells 
arise. The tolerogenic potency of deaggregated human 7-globulin  (dHGG) 1 adminis- 
tered  in  utero  via the maternal  circulation  was  assessed  in  BALB/cCr mice.  When 
tested at  various times  during adult  life, the offspring of these treated  mothers were 
found  to be completely  and  specifically unresponsive  to  an  HGG  challenge  at  the 
level  of both  T  and  B  cells.  Foster  nursing  experiments  indicated  that  sufficient 
transplacental  transfer  of HGG  occurred  over a  4-d  period  to render  the offspring 
unresponsive.  Waning  of unresponsiveness  began  to occur past  the  12th  wk of age 
unless additional  dHGG was administered.  It was during, but not before, the period 
when  the  unresponsive  state  was  breaking  that  HGG-specific  suppressor  cells  were 
found. In contrast, suppressor cells found in adult  HGG tolerized animals appear to 
be associated with either the establishment  and/or maintenance of the unresponsive 
state  (14,  15, 28). The evidence presented in this paper is thereby consistent with the 
clonal deletion/abortion  view of self-tolerance. 
Materials  and Methods 
Animals.  Inbred BALB/cCr mice of  both sexes were obtained from pedigree lines maintained 
at the University of Alberta Animal Breeding Facility, Alberta, Canada. The age of animals is 
specified in the text. 
Antigens.  Human  y-globulin  (HGG)  and  chicken y-globulin  (CGG)  were obtained  from 
Sigma Chemical Co., St. Louis, Mo., and Miles Laboratories, Inc., Kankakee, Ill., respectively, 
and  used  without  further  purification  as  Cohn  fraction  II.  Mouse  y-globulin  (MGG)  was 
prepared  from  pooled  normal  BALB/cCr  serum  by  ammonium  sulfate  precipitation  and 
dialysis  against  phosphate-buffered  saline  (PBS)  (29).  Bovine  serum  albumin  (BSA)  was 
obtained  from Sigma Chemical  Co.  as the crystalline fraction V  powder.  The antigen  was 
trinitrophenylated (TNP) where indicated according to the procedure of Okuyama and Satake 
by using 2,4,6-trinitrobenzene  sulfonic acid  purchased  from Sigma Chemical  Co.  (30).  The 
molar conjugation ratio of TNP to protein was determined on the basis of dry weight and the 
extinction coefficient of TNP-lysine (~ --  15,400 at 348 nm, pH 7.4). These ratios were 10-15 
mol TNP per mole of serum protein for all haptenated preparations used in these experiments. 
Sheep erythroeytes (SRBC) and burro erythrocytes (BRBC) were obtained in Alsever's solution 
from animals  maintained  by the Provincial Laboratory of Public Health,  Alberta,  Canada, 
and from Colorado Serum Company Laboratories, Denver, Colo., respectively. Trinitrophen- 
ylated sheep erythrocytes (TNP-SRBC) were prepared according to the method of Rittenberg 
and Pratt (31). 
Induction of Unresponsiveness.  Unresponsiveness to HGG was induced by a single intravenous 
injection of HGG deaggregated by ultracentrifugation at  100,000 g for 180 rain at 4°C in an 
SW 50.1 rotor on a Beckman model L3-50 Ultracentrifuge (Beckman Instruments, Inc., Palo 
Alto, Calif.). The upper one-third of the supernate was carefully removed for immediate use as 
tolerogen. BALB/cCr females gestating syngeneic fetuses  were injected with 5 mg of dHGG or 
0.05 rag dHGG as indicated in the text. 
t Abbreviations used in this paper: BRBC, burro erythrocytes; BSA, bovine serum albumin; CGG, chicken 
y-globulin; dHGG, deaggregated human y-globulin; DNP, dinitrophenyl; GVH, graft-versus-host; HGG, 
human y-globulin; MGG, mouse y-globulin; MS, mannitol-saline solution; PBS, phosphate-buffered saline; 
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Treated  mothers  were  found  to  be  unresponsive  to  HGG  based  on  absence  of passive 
hemagglutination  titers  and  splenic  plaque-forming  cells  (PFC)  during  the  prenatal  and 
postnatal  periods,  respectively, up  to  6  wk  (C.  Waters,  unpublished  data).  Experiments 
involving induction of unresponsiveness in adults utilized 8-wk-old mice of both sexes that had 
received a single intravenous injection of 5 mg dHGG 17 d previously. 
Immunizations.  To prepare a strongly immunogenic form of protein antigen, the protein was 
alum-precipitated according to  the  technique  of Proom  (32)  and  washed  three  times with 
saline. For assay of T-cell responsiveness, 0.5 mg of alum-aggregated protein and  1.5  ×  109 
killed Bordetella pertussis organisms  (Connaught  Laboratories, Willowdale, Ontario, Canada) 
were  given  intraperitoneally, followed 4  d  later by 0.5  mg of alum-aggregated haptenated 
protein and  1.5  ×  109 B. pertussis. In a  procedure found to give optimal PFC responses, an 
additional i.p. injection of 0,5 mg aggregated haptenated protein was given 2 d  later. Spleens 
were assayed individually for anti-TNP  PFC  10 d  after the  initial administration of alum- 
aggregated protein. Numbers of anti=TNP PFC per spleen were taken as a measure of carrier 
function in these animals. To determine B-cell responsiveness, animals were challenged intra- 
venously with 0.2 ml of a  10% suspension (approximately 10  a cells) of HGG-conjugated BRBC. 
HGG used for erythrocyte conjugation was obtained from Miles Laboratories. The conjugation 
procedure used to prepare the antigen was the CrCI3 technique of Gold and Fudenberg (33); 
the extent  of conjugation was determined by passive hemagglutination of coated cells with 
rabbit anti-human IgG antiserum obtained from Miles Laboratories, Inc. Little variation (~ 1 
serial twofold dilution) was observed in the degree of HGG substitution among different HGG- 
BRBC preparations. Spleens of challenged mice were individually assayed for anti-HGG and 
anti-BRBC PFC 6 d later. 
Cell Suspensions.  Spleens were removed aseptically, minced, and gently pressed through a 
fine mesh stainless steel sieve into either cold Mishell-Dutton balanced salt solution or Leibowitz 
medium containing 5%  fetal calf serum  (Grand Island Biological Co., Grand Island, N.  Y.). 
Cell aggregates were disrupted further by aspiration with a  Pasteur pipette. After removing 
large cell clumps and debris by settling at 1 g for 8 rain, the cells were washed three times with 
medium at 4°C and viability estimated by eosin dye exclusion. 
Hemolytic Plaque Assay.  The  technique  of Cunningham  and  Szenberg  (34)  was  used  to 
determine numbers of splenic PFC by using trinitrophenylated sheep erythrocytes as targets in 
the T-cell responsiveness assay and HGG-conjugated sheep erythrocytes as targets to assess B- 
cell responsiveness. The procedure used for conjugation of HGG (Miles Laboratories, Inc.) to 
erythrocytes was a  modification by Dr. T. Mosmann of this department of the carbodiimide 
method of Golub et al. (35). Briefly, SRBC were washed twice with PBS at 4°C then once with 
mannitol-saline solution (0.35 M d-mannitol [Sigma Chemical Co.], 0.01  M  NaCI). SRBC (0.4 
ml packed cells) were resuspended at  10% in mannitol-saline (MS) for coupling. In a separate 
vessel, 200/tl HGG (Miles Laboratories, Inc.) were dissolved in MS at 0.25 mg/ml and reacted 
for 2 min at 21 °C with 200 #1 of 1-ethyl-3 (3-dimethyl-amino-propyl)-carbodiimide  HCI at  1 
mg/ml in MS. This solution was added to 4 mi of the 10% erythrocyte suspension, mixed, and 
the reaction allowed to proceed for 60 min at 21 °C. HGG-conjugated cells were washed twice 
in PBS and the extent of coupling determined by passive hemagglutination and  lysis in the 
presence of 4% guinea pig complement and rabbit anti-human IgG antiserum obtained from 
Miles Laboratories, Inc.  Very little variation  (~1  serial twofold dilution) was found among 
different  preparations. This  modified procedure requires  far  less  protein  for coupling than 
techniques previously described by others. 
Guinea  pig  serum  (Flow  Laboratories,  Inc.,  Rockville,  Md.)  was  used  as  a  source  of 
complement. Rabbit anti-mouse y-globulin (N. L. Cappel Laboratories, Inc., Cochranville, Pa.) 
was used to amplify indirect  (IgG) PFC at a  concentration found to be optimal.  19S  (IgM) 
PFC reported here are those obtained by assay of individual spleens after the background PFC 
response to normal unconjugated erythrocytes had been subtracted. Numbers of cells secreting 
7S  (IgG) immunoglobulin are reported as the difference between assays done in the presence 
and absence of anti-globulin antiserum as described by Miller and Sprent (36). 
Serum Antibody  Titers.  Anti-HGG  titers  in  the  serum  of mothers  receiving dHGG  were 
determined by passive hemagglutination of HGG-coated SRBC (33) at a final concentration of 
2.5%. 
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before the mating of those animals which were to be treated with dHGG during pregnancy. 
Treated mothers were given 5 mg dHGG on day  14 of pregnancy. After the normal foster 
mothers had delivered their own litters and 1 d before their natural day of birth, the offspring 
of dHGG-treated mothers were delivered by caesarean section and transferred to the normal 
lactating mothers. All neonates that were transferred survived. 
Irradiation.,  12- to  15-wk-old  BALB/cCr recipients received a whole body dose of 750 rads 
from a 137Cs source in a Gammacell 40 irradiation chamber (Atomic Energy of Canada, Ltd., 
Ottawa, Canada) 24 h before cell reconstitution. Animals were housed two to three per cage 
and maintained on a diet of Purina pellets and acidified-chlorinated water containing tetra- 
eycline. 
Cell Transfer.  A cell-transfer system similar to that described by Doyle et al. was used (14). 
Briefly, spleen cell suspensions were made as described above in Leibowitz medium containing 
5%  fetal  calf serum  (Grand  Island Biological Co.,  Grand  Island,  N.  Y.)  and  0.1  mg/ml 
gentamicin (Schering Corp., Kenilworth, N. J.). Mixtures of 5-7 ×  10  v normal 8- to 10-wk-old 
spleen cells and/or an equal number of spleen cells from in utero tolerized mice were injected 
intravenously  into irradiated recipients. Immediately  after cell reconstitution,  recipients received 
intraperitoneally  0.5 mg of heat-aggregated HGG (37) and 0.1 ml of a  10% suspension of thrice- 
washed BRBC (-~ t08 cells) in saline. 7 d later, each animal received intravenously 0.1 ml of a 
10% BRBC suspension as well as 0.2 ml of a  10% suspension of syngeneic erythroeytes coated 
with HGG by the CrCla method described above. This protocol consistently generated high 
anti-HGG  7S  PFC  responses  and  considerably reduced  the  variability inherent  in  other 
immunization regimens. 7 d  later, the animals were sacrificed and splenic PFC individually 
enumerated on either BRBC  target  cells  or on SRBC  coated  with  HGG by the  modified 
method by Golub et al. described above. 
Another series  of cell-transfer experiments utilized a  system similar to that  described by 
Basten and colleagues (16) in which 2  ×  107 HGG primed spleen cells and 5  ×  106 anti-Thy 
1 +  complement-treated DNP primed spleen cells were admixed with 8  ×  10  7 normal or in 
utero tolerant cells and injected intravenously into irradiated recipients. Each recipient was 
challenged immediately with an intraperitoneal injection of 0.5 mg of alum-aggregated TNP- 
HGG which was repeated 2 d later. Animals were sacrificed 7 d after the initial challenge and 
splenic PFC enumerated as previously described. 
Anti-Thy l  Treatment.  Hyperimmune anti-Thy 1 antibodies were raised in AKR/J mice by 
the technique of Reif and Allen (38); the antiserum was a  gift of Dr. C. Shiozawa from this 
department. Both agarose-absorbed guinea pig serum and, in one experiment, rabbit serum 
absorbed as described by Boyse et al. (39) were used as a complement source.  Spleen cells were 
resuspended at  a  cell  concentration of 2  ×  107/ml  in anti-Thy 1 serum diluted  1:12. After 
incubation for 30 min at 4°C an equal volume of absorbed guinea pig complement at a final 
dilution of 1:6 was added and the mixture incubated for  45  min at  37°C. This treatment, 
which routinely reduced spleen cell viability by 30-35%, completely abolished (>98%)  the 
adoptive 7S PFC response of normal spleen cells to SRBC and markedly reduced (>82%)  the 
19S SRBC response. 
Nylon-Wool Cell Filtration.  Spleen cells were passed through nylon-wool columns essentially 
as described by Julius et al. (40). Nylon-wool FT-242 was purchased from Fenwall Laboratories, 
Morton Grove, Ill. 
Preparation of Iodinated Antigens.  Carrier-free  Na  125I purchased  from  Amersham  Corp. 
(Oakville, Ontario, Canada) was used to iodinate HGG (Miles Laboratories, Inc.), according 
to the method of Greenwood et al. (41). Briefly,  12sI was added to  100 p.g protein dissolved in 
1 ml of PBS; this was followed by addition of 65/~g (25 btl) of chloramine-T and incubation for 
3  min at  21°C.  The  reaction  was  stopped  by  the  addition of  1.5  mg  (50  ~1)  of sodium 
metabisulfite and the product dialyzed free of excess ~zsI by several changes of saline at 4°C. 
For use in radioimmunoassay, 12~I-HGG required chromatography on a  calibrated 0.8  ×  37 
cm Sephacryl column (S-200 Fine, Pharmacia Fine Chemicals, Uppsala, Sweden) to remove 
aggregated material which contributed to an otherwise high background. 
Radioimmunoassay.  125I-HGG  (50 #1 in saline; 5,000 cpm) was added after chromatography 
to  mouse serum  (20 #1)  and 50 #1  of rabbit anti-human IgG  (IgG fraction, N.  L.  Cappel 
Laboratories)  at  a  dilution which precipitated  --70%  of labeled material. The mixture was 
diluted with 0.5 ml of 50% normal rabbit serum (Grand Island Biological Co.)  in 0.2 M  Tris- 1138  TOLERANCE INDUCTION  DURING ONTOGENY 
HC1 buffer, pH 7.2, as described by Desbuquois and Aurbach (42). The solution was mixed 
thoroughly and incubated for 17 h at 4°C followed by addition of 0.5 ml of 7.5% polyethylene 
glycol-6000  (J. T. Baker Chemical Co., Phillipsburg, N. J.) in 0.2 M Tris. HCI, pH 7.2. The 
mixtures were centrifuged at  1,000 g for 60 min. Precipitates were washed once with  1 ml of 
3.8% polyethylene glycol-6000  in  0.2  M  Tris-HC1  and  the  washing  added  to  the  previous 
supernate. The activity (cpm) in both the precipitate and combined supernates was determined 
on a Beckman Gamma 300 System (Beckman Instruments, Inc., FuUerton,  Calif.). 
Statistics.  Data analysis was carried out by computer with either analysis of variance and 
the Newman-Keuls multiple range test or Student's t test where applicable. The Wilcoxon rank 
sum  test  was  used  in  one  application  (primed  cell  adoptive  transfer)  where  nonnormal 
distributions precluded the use of the t test. 
Results 
Both  T- and B-Cell Populations are Rendered Specifically Unresponsive by Exposure to HGG 
In  Utero.  Offspring of BALB/cCr  mothers that  had  received dHGG during  preg- 
nancy  were  challenged  repeatedly  with  TNP-HGG to  assess carrier responsiveness 
(Fig.  1 a). All litters tested generated <5% of the 7S PFC response of an age-matched 
(11 wk) control litter (P< 0.001). Furthermore, littermates of these HGG unresponsive 
animals challenged with TNP-CGG were completely responsive to the CGG carrier 
determinants.  Similar results were obtained when TNP-BSA was used for challenge. 
Thus, in utero-treated animals displayed specific T-cell unresponsiveness to HGG. 
Immune function in the HGG-specific B-cell population was assessed by immuniz- 
ing  offspring  of  dHGG-treated  mothers  with  HGG-conjugated  BRBC  (Fig.  1 b). 
Because  there  is  little  or  no cross-reactivity at  the  PFC  level  between  BRBC  and 
SRBC  (C. Waters, unpublished data), the anti-HGG response was assayed on HGG- 
conjugated SRBC as target antigen.  All treated mice gave a  normal response to the 
BRBC  determinants  but  gave  no  7S  PFC  response  to  HGG.  Thus,  B  cells  were 
rendered completely and specifically unresponsive to the HGG hapten (P <  0.001) by 
treatment with dHGG in utero. 
Duration  of  T-  and  B-Cell  Unresponsiveness  Is  Correlated  with  Serum  HGG 
Concentration.  Individual  mice treated  with  dHGG in  utero  had  initially  high  but 
progressively declining levels of HGG in their serum as judged by radioimmunoassay 
(Fig.  2).  At  ~12  wk old,  the  serum concentration  of HGG in  treated  offspring fell 
below 4/~g/ml. Before this time, most animals tested in vivo for degree of T- and B- 
cell tolerance fell into response groups that were 5 SD removed from the response of 
a  normal age-matched group (Table I). During the  11-13-wk period, some recovery 
of T-  and  B-cell  responsiveness  could  be observed  with  more animals  falling  into 
response groups within  3-4 SD of the control.  In  the  absence of additional  dHGG 
waning  of HGG  tolerance  progressively  increased  until  by  40  wk  of age,  treated 
animals had recovered full responsiveness. Administration of small amounts of dHGG 
biweekly reversed this effect (Fig. 3). Specific tolerance in the T-cell population could 
be maintained until  50 wk of age, when animals were finally killed, with as little as 
0.1  /~g dHGG biweekly  from  3  wk  of age onward.  B  cells  required  100-fold  more 
dHGG (10/~g) for tolerance to remain virtually complete. 
Diminished  19S Response to  TNP-HGG In  In  Utero Tolerized  Mice  Does Not  Indicate 
Incomplete Carrier Unresponsiveness.  Other  investigators  studying  HGG tolerance  in- 
duced in adults reported significant reduction of the 7S response with less of an effect 
on  the  19S  response  (16).  Similarly,  animals  treated  with  dHGG  in  utero  and WATERS,  PILARSKI,  WEGMANN,  AND  DIENER 
'O 
x  IgG 
~z~_~,... 300-I  a 
200 
~  loo-~ 
IgM 
UNTREATED  d HGG-TREATED  UNTREATED  d HGG-TREATED 
1139 
0 
x 
Z 
80 
6O 
40-  Z 
2 
cL 
0 
m  2O 
0- 
IgG 
IgM  IgM  IgG 
UNTREATED  d HGG-TREATED  UNTREATED  d HGG-TREATED 
FIG.  la.  Specificity and degree of T-cell unresponsiveness induced in  utero to dHGG.  IgM and 
IgG PFC were enumerated in the individual spleens of i l-wk-old mice treated with dHGG in utero 
and challenged with an immunogenic preparation of TNP-HGG or TNP-CGG. Data are presented 
as  the geometric  mean  :t:  SE.  P  values between  groups:  IgG  PFC  to TNP-HGG;  untreated cf. 
dHGG treated, <0.001; IgG PFC to TNP-CGG in littermates: untreated cf. dHGG-treated, >0.05. 
~, TNP-HGG, IgG response; Q, TNP-HGG, IgM response; II, TNP-CGG, IgG response; F-i, TNP- 
CGG, IgM response. 
FIc.  lb.  Specificity and degree of B-cell  unresponsiveness induced in utero to dHGG.  IgM and 
IgG PFC were enumerated in the individual spleens of 8-wk-old mice treated with dHGG in utero 
and  challenged  with  HGG-coupled  BRBC  as  described  in  Materials  and  Methods.  Data  are 
presented as the geometric mean ::tz SE for the immune response to HGG determinants and BRBC 
determinants. P  values between groups: IgG  PFC to HGG;  untreated cf. dHGG-treated, <0.001; 
IgG  PFC  to  BRBC;  untreated cf.  dHGG-treated,  >0.05. ~,  HGG, IgG  response; D,  HGG, IgM 
response; II, BRBC, IgG response; I-1, BRBC, IgM response. 1,000-- 
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FIG. 2.  Rate of disappearance of HGG in serum of in  utero-treated  mice.  Serum samples were 
taken from the retro-orbital plexus of mice of various ages after tolerance induction in utero and 
HGG concentration (#g/ml) individually determined by radioimmunoassay. Data are presented as 
the arithmetic mean of three to four mice per group  +  SD. 6-wk and  14-wk ages:  serum sample 
from a single mouse. 
TABLE  I 
Waning of In Utero-Induced  HGG Tolerance 
Age*  n  X  SD~ 
Percent animals responding within n 
SD units of mean control PFC re- 
sponse 
T-cell response  B-cell response 
wk 
6-8 
2  --  -- 
3  --  -- 
4  --  10 
5  9  10 
11-13  n  ~  I  --  -- 
2  --  -- 
3  6  20 
4  18  30 
5  31  50 
15-18  n  ~  1  --  -- 
2  9  10 
3  25  20 
4  55  40 
5  68  40 
* 10-40 mice per age group. 
n, integer denoting multiple of standard deviation (SD) units from geometric mean 
of normal age-matched controls. WATERS, PILARSKI, WEGMANN, AND  DIENER  1141 
® 
Q. 
0 
10  `5  __ 
8-- 
6-- 
4-- 
2-- 
10  4  -- 
8-- 
6-- 
4-- 
2-- 
10  3  -- 
8-- 
6-- 
4~ 
| 
0 
0 
0  • 
o 
0 
o  | 
0 
O 
dHGG (g/mouse) 
FIG. 3.  Maintenance of in utero induced unresponsiveness in T and B cells with additional dHGG. 
Mice treated in utero with dHGG were given decreasing amounts  (1 mg-1 ng per mouse) ofdHGG 
beginning at 3 wk of age and continuing  biweekly until testing at 50 wk of age. A control group 
received no additional dHGG. One group was challenged  with an immunogenic  preparation of 
TNP-HGG to assess T-cell  unresponsiveness (O); the other group  was  immunized  with  HGG- 
coupled BRBC to assess B-cell unresponsiveness (0). IgG PFC to TNP or to HGG were enumerated 
in individual spleens. 
challenged  with  TNP-HGG  as  described  previously, produced  diminished  but  not 
absent  19S  responses  (--<40% control).  No  significant  19S  response  to  HGG  was 
observed at the B-cell level. Because the 19S response is presumably less T-dependent 
than  the  7S  response,  the  presence  of a  residual  response  even  at  this  time  could 
indicate  incomplete  T-cell  unresponsiveness.  Alternatively,  a  diminished  but  not 
absent  19S  response  may  represent  the  normal  response  of  an  animal  to  HGG 
determinants modified by haptenation, or to the hapten  itself, to which the animal 
had therefore not been rendered unresponsive. To distinguish between these possibil- 
ities, we challenged both in utero dHGG-treated and adult dHGG-treated mice with 
trinitrophenylated autologous  y-globulin (TNP-MGG)  using the same assay condi- 
tions as above (Fig. 4).  Both  treated groups generated  indistinguishable (P >  0.05) 
19S responses to TNP-MGG  which were comparable to those made by normal groups 
(P  >  0.05).  Because  normal  individuals  should  be  unresponsive  to  their  own  y- 
globulins,  the  presence  of a  19S  TNP  response  in  all  three  groups  indicates  the 
involvement of either TNP-specific help or chemical modification of the HGG carrier, 
or both. We therefore restricted our analysis of HGG  tolerance induced  in  utero to 
the 7S PFC response in the following experiments. 1142  TOLERANCE  INDUCTION  DURING  ONTOGENY 
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FIG. 4.  IgM PFC response of adult tolerized and in utero tolerized mice. Mice were either treated 
with dHGG in utero or as adults 17 before challenge. At 10 wk of age, groups of control, in utero, 
and adult dHGG-treated mice were challenged with an immunogenic preparation of either TNP- 
HGG or TNP-MGG. IgM PFC were enumerated in individual spleens. Data are presented as the 
geometric mean  +  SE. P values between groups: IgM PFC to TNP~MGG; untreated cf. dHGG- 
treated as adults or in utero, >0.05; dHGG-treated as adults cf. dHGG-treated in utero, >0.05. D, 
TNP. MGG; [], TNP • HGG. 
Administration of HGG In  Utero Is Suffi'cient for  Tolerance Induction.  Although dHGG- 
treated mothers made no demonstrable immune response to the antigen during either 
the pregnancy or the weaning period (C. Waters, unpublished data), it is necessary in 
considering the general case of natural self-tolerance to exclude the  possibility that 
dHGG-treated  mothers  influenced the  immune status  of their offspring by  factors 
other than  19S  or  7S  antibody in the colostrum or milk. Thus, we devised a  foster 
nursing experiment in which normal lactating mothers were used to foster nurse the 
caesarean-delivered offspring of dHGG-treated mothers (Fig. 5). When challenged at 
6  wk of age,  dHGG-treated litters  nursed either  by their own or  by normal foster 
mothers were completely unresponsive to TNP-HGG. At  11-12 and 17-18 wk of age, 
when  waning of T-cell  unresponsiveness can  normally be  observed,  both  treated 
groups  made  low  but  indistinguishable 7S  PFC  responses  (P  >  0.05).  Thus  we 
conclude that  this brief period of in utero exposure to  dHGG  (4  d)  is sufficient to 
induce carrier unresponsiveness. 
Maternal HGG Concentration and In Utero Tolerance Induction.  Females made pregnant 
15 d  earlier were given intravenously either 5 mg or 0.5 mg dHGG. The offspring of 
these treated females were challenged with TNP-HGG at  11  wk of age to determine 
the effect of the dose of dHGG on the degree of carrier-specific unresponsiveness (Fig. 
6).  Animals treated  with  a  low  dose  (0.05  mg)  gave  40-50%  of a  normal  7S  PFC 
response  while  animals treated  with  a  high  dose  (5  mg)  gave  a  characteristic  5% 
normal response. Thus a  100-fold lower dose of dHGG was considerably less effective 
in inducing long-lived T-cell unresponsiveness. 
Mechanism  of In  Utero Induced  HGG  Unresponsiveness.  A  number of  investigators WATERS,  PILARSKI, WEGMANN, AND  DIENER  1143 
Fro. 5.  Degree ofT-cell unresponsiveness of in utero-treated  mice foster nursed by normal mothers. 
At 6, 11, and 17 wk of age, groups of mice treated in utero with dHGG and nursed by their own or 
a foster mother were challenged  with an immunogenic  preparation of TNP-HGG. IgG PFC were 
enumerated in  individual spleens. Data are presented  as the geometric  mean  +  SE.  P  values 
between groups: litter of untreated mothers cf. litter of either treated mother nursed by the same or 
litter of treated mother nursed by untreated foster mother, <0.001 at all three ages of testing; litter 
of treated mother nursed by the same cf. litter of treated mother foster nursed by untreated mother, 
>0.05 at all three ages of testing. ~, litter of untreated mother; ~], dHGG-treated litter foster nursed 
by untreated mother; !  dHGG-treated litter nursed by own mother. 
studying  unresponsiveness  to  HGG  induced  in  adult  animals  have  reported  the 
existence  of  specific  suppressor  cells  associated  with  at  least  some  phases  of  the 
unresponsive state  (14-16).  We have endeavored to examine  this question  in  the in 
utero  system  by  using  similar  adoptive  cell  transfer  regimens.  Lethally  irradiated 
animals were reconstituted with  5-7  ×  10 v normal  adult spleen cells admixed with 
an equal number of either spleen cells from animals treated in utero with dHGG  or 
untreated age-matched cells. Cell transfer was followed by immediate intraperitoneal 
challenge with 0.5 mg of heat-aggregated HGG.  7 d  later, an additional challenge of 
l0  s  HGG-conjugated  syngeneic  erythrocytes  was  given  intravenously,  This  assay 
procedure  induced  consistently  good  7S  PFC  responses  to  HGG-  and  considerably 
reduced  the  variability of the  response  inherent  in  other  immunization  regimens. 
Admixture of equal numbers of normal and  14-wk-old in utero dHGG-treated spleen 
cells and  transfer to irradiated recipients resulted in  a  70%  reduction  of the normal 
response (Fig. 7). Little additional suppression was observed if twice as many treated 
spleen cells were added  (C.  Waters,  unpublished  data).  Furthermore,  an equivalent 
number  of  normal  age-matched  spleen  cells  admixed  with  normal  cells  did  not 
suppress. Challenge of animals receiving the cell mixtures above with BRBC revealed 
that suppression was specific; spleen cells from mice treated in utero with dHGG  did 
not  suppress the BRBC  response.  Spleen cells from older mice treated in utero with 
dHGG  also specifically suppressed the HGG response, often to a  greater extent. 
Contrary to expectations, no suppression of this nature was found when spleen cells 1144  TOLERANCE  INDUCTION  DURING  ONTOGENY 
Fie.  6.  Degree  of T-cell  unresponsiveness in  offspring of mice  receiving  different  amounts  of 
dHGG during pregnency. At  11 and  15 wk of age, offspring of mice treated during pregnancy with 
5  mg or 0.05  mg dHGG  were challenged with an immunogenic preparation  of TNP-HGG.  IgG 
PFC were enumerated in individual spleens. Data are presented as the geometric mean  +  SE.  P 
values between groups: untreated cf. litter of mother receiving 0.05 mg dHGG; >0.05 at both ages 
of testing; untreated cf. litter of mother receiving 5.0 mg dHGG, <0.001  at both ages of testing. I~, 
untreated; [], 0.05 mg dHGG; R, 5 mg dHGG. 
Ftc.  7.  Presence of active suppression in spleens of 14-wk-old mice treated  in utero with dHGG. 
Adoptive cell transfer to irradiated  recipients of 7  ×  [07 normal or tolerant spleen cells alone or a 
1  : 1 mixture of both populations was followed by intraperitoneal challenge with both heat-aggregated 
HGG and BRBC. After an additional challenge as described in Materials and Methods, mice were 
sacrificed  and  IgG  PFC  to  HGG  and  BRBC  were  enumerated  in  individual  spleens.  Data  are 
presented as the geometric mean  ±  SE.  P  values between groups: IgG PFC to HGG: recipients of 
normal cells cf. recipients of 1:1 mixture of normal and tolerant cells, <0.02; cf. recipients of tolerant 
ceils, <0.001; cf. recipients of 1:1 mixture of normal and of normal 14-wk-old cells, >0.05. IgG PFC 
to BRBC; normal cell recipients cir. all other groups >0.05. ~, HGG; Q, BRBC. WATERS, PILARSKI. WEGMANN, AND DIENER  1145 
Fic, 8.  Absence  of active suppression in spleens of 5-wk*old mice treated in utero with dHGG. 
Adoptive cell transfer to irradiated recipients of 7 ×  107 normal or tolerant spleen cells alone or a 
t: l mixture of both populations was followed  by intraperit0neal challenge  with both heat-aggregated 
HGG and BRBC. After a secondary challenge as described in Materials and Methods, mice were 
sacrificed and IgG PFC to HGG and BRBC were enumerated in individual spleens. Data are 
presented as the geometric mean :t: SE. P values between groups: IgG PFC to HGG; recipients of 
normal cells cf. recipients of a  1:1  mixture of normal and tolerant cells, >0.05; cf. recipients of 
tolerant cells, <0.001 ; el. recipients of l : l mixture of normal and normal 5-wk-old  cells, >0.05. IgG 
PFC to BRBC: recipients of normal cells cf. all other groups >0.05. ~1, HGG; [], BRBC. 
from younger in utero-treated mice were admixed with normal cells (Fig. 8).  Cells 
from 4- to 6-wk-old mice treated in utero with dHGG consistently failed to suppress 
the HGG response even when twice as many tolerant cells were added  (C. Waters, 
unpublished data). As before, tolerance was stable upon adoptive transfer. This lack 
of suppression by spleen cells from 4- to 6-wk-old tolerant mice would not have been 
predicted if the mechanism maintaining the tolerant state requires suppressor partic- 
ipation. HGG tolerance began to break down in in utero-treated mice at  14 wk of age 
or older although the tolerant state remained stable in 4- to 6-wk-old in utero-treated 
mice. 
We have also utilized an adoptive cell-transfer system similar to that described by 
Basten and colleagues in which DNP-primed B cells and HGG-primed spleen as a T- 
cell source are  admixed  in an optimal ratio  (16).  Again, suppression was  observed 
when older in utero-treated mice were used as tolerant cell donors at  a  4:1  ratio of 
tolerant  to  normal cells.  Spleen cells  from  younger in  utero-treated  mice  did  not 
suppress.  The  strength  of suppression observed  in  this  system  was  somewhat  less 
dramatic, however, than with the system utilizing normal unprimed spleen cells (C. 
Waters, unpublished data). 
The cell population responsible for active suppression in transfers of spleen cells 
from  14-  to  33-wk-old  in  utero-treated  mice  was  relatively  resistant  to  a  single 
treatment  with  anti-Thy  1  +  complement. Partial  restoration of unresponsiveness 
(20-60% of the normal control group)  was achieved after treatment of the in utero 
tolerized cell population and subsequent admixture with normal cells (P_< 0.02 with 
respect  to  the  suppressed  group).  In  two  of our  experiments with  nylon-wool cell 1146  TOLERANCE INDUCTION  DURING  ONTOGENY 
filtration, restoration levels of 75-95%  of the normal  response were achieved  (P < 
0.05 with respect to the suppressed group). 
Discussion 
In  this  paper,  we  describe experiments designed  to elucidate the  mechanism  of 
natural  self-tolerance  by  comparison  with  a  model  system  in  which  antigen  is 
administered in utero before immunocompetent cells arise. Insofar as any such model 
which relies on the use of extrinsic antigens can conform to possibly peculiar structural 
properties or modes of presentation germane to true self-antigens, this system at least 
rules out interference from regulatory effector functions in immunocompetent animals. 
The  latter may render difficult the extrapolation of data obtained  from adults  or 
possibly even neonatally tolerized animals to self-tolerance. Furthermore, unrespon- 
siveness in this system is not achieved or amplified by nursing or by serum factors, 
making it unlike several others which have been proposed as models for self-tolerance 
(4, 43). There have been reports of the induction of unresponsiveness via the maternal- 
fetal route; the mechanisms of the unresponsive states, however, were not investigated 
(44-46). 
The basic experimental protocol involved the administration of deaggregated HGG 
to BALB/cCr mice during pregnancy and the subsequent assessment of T- and B-cell 
immunocompetence towards this antigen during the postnatal  life of the offspring. 
The mechanism responsible for the unresponsive state so induced was then investi- 
gated  in  cell-transfer studies.  For  example,  offspring  of pregnant  mice  that  had 
received a specified quantity of dHGG in utero were completely unresponsive at both 
the T- and  B-cell level for a  substantial  portion  (> 12 wk)  of their adult  lives. The 
specificity of the tolerant state in the case of T  cells was established by showing that 
littermates of HGG unresponsive animals  gave normal responses when  immunized 
with one of two haptenated  noncross-reaeting carriers, TNP-CGG and TNP-BSA. 
Specificity of B-cell  tolerance  was  demonstrated  by  showing  that  animals  made 
unresponsive  in  utero  to  HGG generated  normal  PFC  responses  to BRBC.  B-cell 
unresponsiveness began to slowly disappear in mice at 12 to 18 wk of age. This waning 
occurred in parallel with the breakdown of T-cell unresponsiveness. Although  this 
observation may represent a departure from that of Chiller et al. (37) who found that 
B-cell tolerance to  HGG disappeared  more  rapidly than  T-cell tolerance in  adult 
tolerized animals, we wish to point out that the level of sensitivity of our in situ assay 
and that of the above investigators may not be readily comparable. 
The gradual waning of unresponsiveness correlated with the disappearance of HGG 
from the serum of in utero-treated animals as detected by radioimmunoassay. This 
observation is consistent with Burnet's postulate on self-tolerance which predicts that 
presence of antigen is required to maintain  antigen  specific unresponsiveness. The 
small PFC response that did occur in both B- and T-cell classes upon challenge at  12 
wk of age correlates with a serum HGG concentration of_<4/~g/ml. In addition, we 
found that unresponsiveness to HGG could be maintained if small quantities (0.1-10 
/~g) of dHGG were administered biweekly to in utero-treated animals. 
Although  mice rendered tolerant in utero to HGG gave no detectable  19S  PFC 
response when immunized with HGG coupled to BRBC in the B-ceU assay, it should 
be noted that both littermates of animals treated with dHGG in utero and animals 
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the hapten when challenged with TNP-HGG to test for T-cell tolerance. The degree 
to which in utero treatment actually reduced the  19S response was not immediately 
apparent, however;  animals tolerized either as adults or in utero as well as normal 
controls made similar  19S  responses when challenged with TNP-substituted autolo- 
gous immunoglobulins. These results indicate that T-cell unresponsiveness in in utero- 
treated animals was probably complete; either new antigenic determinants are created 
by trinitrophenylation or TNP-specifie helper-cell activity may have been generated 
by the immunization regimen. 
Foster nursing experiments showed  that a  maximum of 4  d  in  utero exposure to 
HGG was sufficient to achieve a long-lived specific tolerance to HGG in the offspring. 
Thus  tolerance  induction  was  independent  of  maternal  factors  which  could  be 
transmitted  to the fetus by nursing.  In fact, no evidence was found  for a  maternal 
immune response  to  dHGG at  least  at  the  level of agglutinating  antibody  during 
pregnancy.  These  latter  observations  are  in  agreement  with  those  of others  who 
investigated the antibody response of normal adults given a  tolerogenic dose (5 rag) 
ofdHGG  (16,  18). 
The  most  significant  finding  of this  study of tolerance  induced  in  utero  is  that 
suppressor cells do not appear to be associated with the maintenance of the tolerant 
state.  Rather,  active suppression  was routinely found in  mixed spleen-cell transfers 
when  the  tolerant  cell  population  was  derived  from animals undergoing  tolerance 
breakdown  (14-33 wk old).  Suppression was specific for HGG because  19S  and  7S 
PFC responses to an unrelated antigen such as BRBC were normal in irradiated mice 
reconstituted with a  mixture of normal and HGG-treated spleen cells.  No evidence 
for active suppression was found in younger  (4- to 6-wk-old)  in  utero-treated  mice 
where tolerance was intact, even when a 2:1 tolerant to normal-cell ratio was used in 
attempts to inhibit an adoptively transferred immune response to HGG in irradiated 
recipients.  It would therefore appear that within  the limits of detection  defined by 
cell-transfer assays, suppressor cells are not involved in maintaining the HGG unre- 
sponsive state induced in utero. 
The suppressor-cell population in in utero dHGG-treated mice which were partially 
tolerant  at  14-33 wk of age was relatively resistant  to a  single treatment with anti- 
Thy 1 antiserum and complement. It is of interest in this regard that other investigators 
have described a  suppressor cell which expresses Ly 1+2+3 + Qal  + but is also resistant 
to a  single anti-Thy  1 +  complement treatment  (47, 48). Furthermore, they showed 
that Thy 1  + Ly 1  + 2,3- Qal  + help is required in vitro for Ly 1+2+3 + Qal + cells to exert 
potent feedback suppressor effects. Because the data from our in situ assays indicate 
that low levels of T-cell help are available during the period of partial tolerance, it 
would not be unreasonable therefore to expect the appearance of suppressors at this 
time. 
The  fact  that  the  suppressor  cell  population  in  our  experimental  system  was 
partially retained by nylon-wool cell filtration suggests adherent properties similar to 
those of B cells, macrophages or Ly 1+2+3 + amplifiers of suppression. These observa- 
tions  are  somewhat  reminiscent  of those  of other  investigators  who  described  the 
presence of two suppressor-cell populations  in  mice rendered  tolerant  to dHGG as 
adults  (28,  49).  One  cell  type was  anti-Thy  1-sensitive whereas  the  other,  though 
resistant to anti-Ig treatment, had glass-wool adherent properties. 
The results of the experiments reported  here are at  variance with  those of other 1148  TOLERANCE  INDUCTION  DURING  ONTOGENY 
investigators who have induced unresponsiveness in adult immunocompetent animals 
to various antigens including HGG. In the majority of cases, specific suppressor cells 
have been implicated in the induction and/or maintenance of the unresponsive state 
(14-16).  It  is  of course difficult  to establish  causality  in  any case and  at  least  one 
investigator  has  suggested  that  because  HGG  specific  suppressor  cells  are  only 
transiently associated with the HGG unresponsiveness in the adult model, they cannot 
be regarded as obligatory elements for maintaining it  (14).  Moreover, these investi- 
gators have recently demonstrated  that the induction  of suppressor cells along with 
unresponsiveness is a  function  of the source from which  HGG was obtained:  HGG 
isolated from the plasma of a  normal individual or from an IgG1 )~-myeloma did not 
induce  suppressors  but  did  induce  unresponsiveness  (50).  Our  data  are  thus  in 
agreement with those of others who failed to find suppressor cells associated with a 
state of tolerance even in adult animals (2-4). 
The experiments described in this report link the appearance of suppressor cells to 
the breakdown of the in utero tolerant state and represent the first demonstration of 
its kind  for soluble  protein  antigens.  There  is,  however, some precedence for these 
observations  in  reports  on  transplantation  tolerance.  For  example,  rat  leukocyte 
chimeras  have  been  described  in  which  specific suppressor cells  were  absent  until 
tolerance  was  partially  terminated  by  the  adoptive  transfer  of normal  syngeneic 
lymphocytes (7).  These suppressors appeared to be associated with  the homeostatic 
component of an active alloimmune response. 
Current  studies  in this department support and extend  these observations. When 
chimerism was induced in chickens in ovo, animals which presented a partial state of 
unresponsiveness  (no graft-versus-host (GVH) reactivity but specific serum alloanti- 
bodies present) have inhibitory activity for GVH. Suppression, however, is absent in 
animals that are tolerant at both the cell-mediated and humoral levelfl 
The results of our experiments are consistent with the view that suppressor cells do 
not represent an obligatory feature of self-tolerance and that the absence of anti-self 
reactivity reflects a state of central immunological unresponsiveness. 
Summary 
A specific state of T- and B-cell tolerance to human y-globulin (HGG) was induced 
in  utero  by  intravenous  administration  of the  deaggregated  antigen  to  pregnant 
BALB/cCr mice. Tolerance persisted  in the offspring until  the  12th-wk of age and 
then  began  to  gradually  disappear.  Suppressor  cells  could  only  be  found  when 
responsiveness to HGG ultimately appeared in the in utero-treated animals but not 
when they were completely unresponsive. In contrast, HGG-specific suppressors found 
in animals made unresponsive to HGG as adults appear to be associated with either 
the establishment and/or maintenance of the unresponsive state. To the extent that 
these experiments are consistent  with  natural  self-tolerance to a  serum protein, we 
conclude that active suppression is not a prerequisite from maintenance of unrespon- 
siveness to self. 
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